Hypha Labs, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Hypha Labs, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Sep 30, 2017 | $1.90M | Dec 29, 2017 |
| FY2017 | Sep 30, 2016 | $818.6K | Dec 29, 2017 |
| FY2016 | Sep 30, 2015 | $16.1K | Jan 9, 2017 |
| FY2015 | Sep 30, 2014 | $54.9K | Jan 13, 2016 |
| FY2014 | Sep 30, 2013 | $567.2K | Nov 25, 2014 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Sep 30, 2022 | $2.70M | Jan 17, 2023 |
| FY2022 | Sep 30, 2021 | $2.50M | Jan 17, 2023 |
| FY2021 | Sep 30, 2020 | $2.57M | Dec 29, 2021 |
| FY2020 | Sep 30, 2019 | $2.55M | Jan 29, 2021 |
| FY2019 | Sep 30, 2018 | $2.84M | Dec 31, 2019 |
| FY2018 | Sep 30, 2017 | $1.90M | Dec 27, 2018 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Sep 30, 2013 | $567.2K | Dec 30, 2013 |
| FY2013 | Sep 30, 2012 | $391.7K | Dec 30, 2013 |
| FY2011 | Sep 30, 2011 | $95.9K | Dec 29, 2011 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Sep 30, 2022 | $1.07M | Jan 17, 2023 |
| FY2022 | Sep 30, 2021 | $715.2K | Jan 17, 2023 |
| FY2021 | Sep 30, 2020 | $795.8K | Dec 29, 2021 |
| FY2020 | Sep 30, 2019 | $839.8K | Jan 29, 2021 |
| FY2019 | Sep 30, 2018 | $770.1K | Dec 31, 2019 |
| FY2018 | Sep 30, 2017 | $994.0K | Dec 27, 2018 |
| FY2017 | Sep 30, 2016 | $438.5K | Dec 29, 2017 |
| FY2016 | Sep 30, 2015 | ($69.5K) | Jan 9, 2017 |
| FY2015 | Sep 30, 2014 | $25.7K | Jan 13, 2016 |
| FY2014 | Sep 30, 2013 | $263.2K | Nov 25, 2014 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($3.10M) | Jan 15, 2026 |
| FY2025 | Sep 30, 2024 | ($785.4K) | Jan 15, 2026 |
| FY2024 | Sep 30, 2023 | $246.8K | Jan 13, 2025 |
| FY2023 | Sep 30, 2022 | ($2.06M) | Jan 19, 2024 |
| FY2022 | Sep 30, 2021 | ($686.5K) | Jan 17, 2023 |
| FY2021 | Sep 30, 2020 | ($2.31M) | Dec 29, 2021 |
| FY2020 | Sep 30, 2019 | ($1.81M) | Jan 29, 2021 |
| FY2019 | Sep 30, 2018 | ($1.65M) | Dec 31, 2019 |
| FY2018 | Sep 30, 2017 | ($1.07M) | Dec 27, 2018 |
| FY2017 | Sep 30, 2016 | ($3.70M) | Dec 29, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($3.00M) | Jan 15, 2026 |
| FY2025 | Sep 30, 2024 | ($1.83M) | Jan 15, 2026 |
| FY2024 | Sep 30, 2023 | ($437.4K) | Jan 13, 2025 |
| FY2023 | Sep 30, 2022 | ($1.15M) | Jan 19, 2024 |
| FY2022 | Sep 30, 2021 | ($772.4K) | Jan 17, 2023 |
| FY2021 | Sep 30, 2020 | ($2.19M) | Dec 29, 2021 |
| FY2020 | Sep 30, 2019 | ($1.84M) | Jan 29, 2021 |
| FY2019 | Sep 30, 2018 | ($1.76M) | Dec 31, 2019 |
| FY2018 | Sep 30, 2017 | ($1.30M) | Dec 27, 2018 |
| FY2017 | Sep 30, 2016 | ($2.88M) | Dec 29, 2017 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Sep 30, 2015 | $143.8K | Jan 13, 2016 |
| FY2015 | Sep 30, 2014 | $23.1K | Jan 13, 2016 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($380.0K) | Jan 15, 2026 |
| FY2025 | Sep 30, 2024 | ($1.03M) | Jan 15, 2026 |
| FY2024 | Sep 30, 2023 | $112.5K | Jan 13, 2025 |
| FY2023 | Sep 30, 2022 | ($184.8K) | Jan 19, 2024 |
| FY2022 | Sep 30, 2021 | ($136.0K) | Jan 17, 2023 |
| FY2021 | Sep 30, 2020 | ($671.6K) | Dec 29, 2021 |
| FY2020 | Sep 30, 2019 | ($1.04M) | Jan 29, 2021 |
| FY2019 | Sep 30, 2018 | ($163.4K) | Dec 31, 2019 |
| FY2018 | Sep 30, 2017 | ($376.9K) | Dec 27, 2018 |
| FY2017 | Sep 30, 2016 | ($734.1K) | Dec 29, 2017 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $33.0K | Jan 15, 2026 |
| FY2025 | Sep 30, 2024 | $27.7K | Jan 15, 2026 |
| FY2022 | Sep 30, 2022 | $17.7K | Jan 17, 2023 |
| FY2022 | Sep 30, 2021 | $56.2K | Jan 17, 2023 |
| FY2021 | Sep 30, 2020 | $141.2K | Dec 29, 2021 |
| FY2020 | Sep 30, 2019 | $45.1K | Jan 29, 2021 |
| FY2019 | Sep 30, 2018 | $207.4K | Dec 31, 2019 |
| FY2018 | Sep 30, 2017 | $140.8K | Dec 27, 2018 |
| FY2017 | Sep 30, 2016 | $13.8K | Dec 29, 2017 |
| FY2016 | Sep 30, 2015 | $1.44M | Jan 9, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $409.2K | Jan 15, 2026 |
| FY2025 | Sep 30, 2024 | $493.8K | Jan 15, 2026 |
| FY2024 | Sep 30, 2023 | $1.41M | Jan 13, 2025 |
| FY2023 | Sep 30, 2022 | $1.34M | Jan 19, 2024 |
| FY2022 | Sep 30, 2021 | $1.89M | Jan 17, 2023 |
| FY2021 | Sep 30, 2020 | $1.79M | Dec 29, 2021 |
| FY2020 | Sep 30, 2019 | $1.36M | Jan 29, 2021 |
| FY2019 | Sep 30, 2018 | $1.40M | Dec 31, 2019 |
| FY2018 | Sep 30, 2017 | $1.57M | Dec 27, 2018 |
| FY2017 | Sep 30, 2016 | $1.45M | Dec 29, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $2.51M | Jan 15, 2026 |
| FY2025 | Sep 30, 2024 | $1.42M | Jan 15, 2026 |
| FY2024 | Sep 30, 2023 | $3.28M | Jan 13, 2025 |
| FY2023 | Sep 30, 2022 | $3.75M | Jan 19, 2024 |
| FY2022 | Sep 30, 2021 | $2.94M | Jan 17, 2023 |
| FY2021 | Sep 30, 2020 | $2.88M | Dec 29, 2021 |
| FY2020 | Sep 30, 2019 | $930.1K | Jan 29, 2021 |
| FY2019 | Sep 30, 2018 | $384.6K | Dec 31, 2019 |
| FY2018 | Sep 30, 2017 | $164.0K | Dec 27, 2018 |
| FY2017 | Sep 30, 2016 | $211.9K | Dec 29, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($2.44M) | Jan 15, 2026 |
| FY2025 | Sep 30, 2024 | ($1.26M) | Jan 15, 2026 |
| FY2025 | Sep 30, 2023 | ($2.21M) | Jan 15, 2026 |
| FY2024 | Sep 30, 2022 | ($2.74M) | Jan 13, 2025 |
| FY2023 | Sep 30, 2021 | ($1.05M) | Jan 19, 2024 |
| FY2022 | Sep 30, 2020 | ($1.09M) | Jan 17, 2023 |
| FY2021 | Sep 30, 2019 | $425.9K | Dec 29, 2021 |
| FY2020 | Sep 30, 2018 | $1.01M | Jan 29, 2021 |
| FY2019 | Sep 30, 2017 | $1.41M | Dec 31, 2019 |
| FY2018 | Sep 30, 2016 | $1.23M | Dec 27, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Sep 30, 2020 | $592.6K | Dec 29, 2021 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($23.65M) | Jan 15, 2026 |
| FY2025 | Sep 30, 2024 | ($20.55M) | Jan 15, 2026 |
| FY2024 | Sep 30, 2023 | ($19.76M) | Jan 13, 2025 |
| FY2023 | Sep 30, 2022 | ($20.01M) | Jan 19, 2024 |
| FY2022 | Sep 30, 2021 | ($17.95M) | Jan 17, 2023 |
| FY2021 | Sep 30, 2020 | ($17.27M) | Dec 29, 2021 |
| FY2020 | Sep 30, 2019 | ($14.96M) | Jan 29, 2021 |
| FY2019 | Sep 30, 2018 | ($13.15M) | Dec 31, 2019 |
| FY2018 | Sep 30, 2017 | ($11.50M) | Dec 27, 2018 |
| FY2017 | Sep 30, 2016 | ($10.43M) | Dec 29, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Sep 30, 2022 | $56.2K | Jan 17, 2023 |
| FY2022 | Sep 30, 2021 | $295.9K | Jan 17, 2023 |
| FY2021 | Sep 30, 2020 | $82.7K | Dec 29, 2021 |
| FY2020 | Sep 30, 2019 | $323.7K | Jan 29, 2021 |
| FY2019 | Sep 30, 2018 | $176.0K | Dec 31, 2019 |
| FY2018 | Sep 30, 2017 | $178.2K | Dec 27, 2018 |
| FY2018 | Sep 30, 2016 | $135.4K | Dec 27, 2018 |
| FY2017 | Sep 30, 2015 | $481.1K | Dec 29, 2017 |
| FY2016 | Sep 30, 2014 | $5.10M | Jan 9, 2017 |
| FY2015 | Sep 30, 2013 | $35.4K | Jan 13, 2016 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 0 | Jan 15, 2026 |
| FY2025 | Sep 30, 2024 | 0 | Jan 15, 2026 |
| FY2024 | Sep 30, 2023 | 0 | Jan 13, 2025 |
| FY2023 | Sep 30, 2022 | 0 | Jan 19, 2024 |
| FY2022 | Sep 30, 2021 | 0 | Jan 17, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 0 | Jan 15, 2026 |
| FY2025 | Sep 30, 2024 | 0 | Jan 15, 2026 |
| FY2024 | Sep 30, 2023 | 0 | Jan 13, 2025 |
| FY2023 | Sep 30, 2022 | 0 | Jan 19, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 147.12M | Jan 15, 2026 |
| FY2025 | Sep 30, 2024 | 123.05M | Jan 15, 2026 |
| FY2024 | Sep 30, 2023 | 87.10M | Jan 13, 2025 |
| FY2023 | Sep 30, 2022 | 75.15M | Jan 19, 2024 |
| FY2022 | Sep 30, 2021 | 71.23M | Jan 17, 2023 |
| FY2021 | Sep 30, 2020 | 58.27M | Dec 29, 2021 |
| FY2020 | Sep 30, 2019 | 48.36M | Jan 29, 2021 |
| FY2019 | Sep 30, 2018 | 42.25M | Dec 31, 2019 |
| FY2018 | Sep 30, 2017 | 35.03M | Dec 27, 2018 |
| FY2017 | Sep 30, 2016 | 22.49M | Dec 29, 2017 |